Study Finds Solution Reduces Mortality Rates in Patients With Pulmonary Embolism

According to, clinical data has validated the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE). The data was presented during the 2024 AVF (American Venous Forum) by Jacob Shapiro, MD, vascular surgeon at TriHealth in Cincinnati, OH.

The real-world study, "Shorter Time to Assessment and Anticoagulation with Decreased Mortality in Patients with Pulmonary Embolism Following Implementation of Artificial Intelligence Software," evaluated the clinical impact of the Viz PE Solution on time to assessment, time to anticoagulation, and patient outcomes at TriHealth. The study found that implementation of the AI-powered solution combined with PERT activation significantly improved time to assessment and time to anticoagulation with a 74% reduction in in-hospital mortality risk.

“Our findings highlight the efficacy and practical application of AI in a clinical setting,” said Jacob Shapiro, M.D., Vascular Surgery Resident at TriHealth in Cincinnati, OH. “We are proud to partner with and utilize their innovative PE solutions to continue advancing the management of this vulnerable patient population.”

“The results of this study mark a significant milestone in our ongoing journey to improve patient outcomes with AI,” said Prem Batchu-Green, senior director of clinical strategy at “By showcasing the real-world impact of the Viz PE Solution on key metrics such as mortality, we are not only validating the effectiveness of our technology but also reaffirming our commitment to driving meaningful change in healthcare for the benefit of patients.”

© Anderson Publishing, Ltd. 2024 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited.